Pseudomonas spp. ISOLATED FROM THE ORAL CAVITY OF HEALTHCARE WORKERS FROM AN ONCOLOGY HOSPITAL IN MIDWESTERN BRAZIL

Rev Inst Med Trop Sao Paulo. 2015 Dec;57(6):513-4. doi: 10.1590/S0036-46652015000600009.

Abstract

This cross-sectional study, performed in an oncology hospital in Goiania, aimed to characterize the prevalence of oral colonization and antimicrobial susceptibility of Pseudomonas spp. isolated from the saliva of healthcare workers. Microorganisms were subjected to biochemical tests, susceptibility profile, and phenotypic detection. Of 76 participants colonized with Gram negative bacilli, 12 (15.8%) harbored Pseudomonas spp. Of all isolates, P. aeruginosa (75.0%), P. stutzeri (16.7%), and P. fluorescens (8.3%), were resistant to cefoxitin, and therefore likely to be AmpC producers. The results are clinically relevant and emphasize the importance of surveillance to minimize bacterial dissemination and multiresistance.

Este estudo transversal, realizado em um hospital oncológico em Goiânia, objetivou caracterizar a prevalência da colonização oral e suscetibilidade antimicrobiana de Pseudomonas spp. isoladas da saliva de profissionais da saúde. Micro-organismos foram submetidos a testes bioquímicos, perfil de sensibilidade e detecção fenotípica. Dos 76 participantes colonizados por bastonetes Gram negativos, 12 (15,8%) albergavam Pseudomonas spp. Todos os isolados, P. aeruginosa (75,0%), P. stutzeri (16,7%) e P. fluorescens (8,3%), foram resistentes à cefoxitina e, portanto, possíveis produtores de AmpC. Os resultados são clinicamente relevantes e enfatizam a importância da vigilância para minimizar a disseminação e a multirresistência bacteriana.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Brazil / epidemiology
  • Cancer Care Facilities*
  • Cefoxitin / therapeutic use
  • Cross-Sectional Studies
  • Health Personnel / statistics & numerical data*
  • Humans
  • Microbial Sensitivity Tests
  • Mouth / microbiology*
  • Prevalence
  • Pseudomonas / isolation & purification*
  • Pseudomonas Infections / epidemiology*
  • Pseudomonas Infections / prevention & control
  • Saliva / microbiology
  • beta-Lactam Resistance / drug effects

Substances

  • Anti-Bacterial Agents
  • Cefoxitin